Advances and opportunities for hiPSC-derived models of the blood-brain barrier

Hannah S. Seo, Pedram Motallebnejad, Samira M. Azarin

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


As the interface between the vasculature and the central nervous system (CNS), the blood-brain barrier (BBB), composed of brain microvascular endothelial cells (BMECs), plays a crucial role in maintaining the health of the CNS but hinders drug delivery. Accordingly, in vitro modeling of the BBB has been and continues to be of great interest to scientists studying neurological diseases and developing therapeutics that must be delivered to the brain. The establishment of human induced pluripotent stem cell-derived BMECs (iBMECs) has addressed a major challenge of in vitro modeling of the BBB by providing a scalable source of BMECs that have key features of the in vivo BBB and facilitate disease-in-a-dish and BBB-on-a-chip applications. As researchers seek to augment the applicability of iBMECs for various studies, models involving iBMECs can be improved by integrating more elements of the in vivo BBB microenvironment.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalCurrent Opinion in Chemical Engineering
StatePublished - Dec 2020

Bibliographical note

Funding Information:
This work was supported by the University of Minnesota and the National Science Foundation Graduate Research Fellowship Program (H.S.S.; grant number 00039202 ).

Publisher Copyright:
© 2020 Elsevier Ltd

Copyright 2020 Elsevier B.V., All rights reserved.


Dive into the research topics of 'Advances and opportunities for hiPSC-derived models of the blood-brain barrier'. Together they form a unique fingerprint.

Cite this